Staff_Development_Banner_Design_13062017_without_fade
 

About NDM

NDM Research Building

The Nuffield Department of Clinical Medicine is part of the Medical Sciences Division. It hosts one of the largest groupings of biomedical researchers in the University sector, and is also responsible for a significant part of the teaching of clinical medical students within the Oxford Medical School.

Events

A Symposium to celebrate the 10th anniversary of the Ludwig Institute

A Symposium to celebrate the 10th anniversary of the Ludwig Institute

Posted 30/06/2017

The Ludwig Institute of Cancer Research in Oxford is marking its 10 year anniversary with a two-day symposium at Keble College Oxford on 11  and 12 September 2017 to share highlights of world-leading research from international Ludwig Cancer Research colleagues and the Oxford community.  Session topics include cancer therapies, gene regulation, epigenetics, immunology, metabolism and genome instability. Limited free registration for University staff and students.

Oxford IBD Masterclass 2017  Personalised care in IBD: the interface between science and practice

Oxford IBD Masterclass 2017 Personalised care in IBD: the interface between science and practice

Posted 21/06/2017

The hugely popular and prestigious Oxford Masterclass will return to the historical setting of the Examination Schools, Oxford University, for its 44th year. This year we shall be joining forces with the Centre for Personalised Medicine, to focus on personalised care in IBD. The meeting will be co-chaired by Professor Simon Leedham and Professor Simon Travis and will run across 2 days: Monday 11th September and Tuesday 12th September.  Register here to attend this year’s Oxford Master Class.

 View events

Latest News

Quick test can predict anaemia in malaria patients treated with artemisinins

Quick test can predict anaemia in malaria patients treated with artemisinins

Posted 20/07/2017

An existing malaria rapid diagnostic test (RDT) can be adapted to predict the delayed anaemia that can complicate severe malaria in patients treated with artemisinin-based antimalarial drugs, say researchers in a study published in Science Translational Medicine Journal.

Professor Sir Peter Ratcliffe awarded Royal Society Buchanan Medal

Professor Sir Peter Ratcliffe awarded Royal Society Buchanan Medal

Posted 18/07/2017

The Royal Society has awarded Professor Sir Peter Ratcliffe, Clinical Research Director at the Francis Crick Institute and Director of the Target Discovery Group at the University of Oxford, with the Buchanan Medal for his ground-breaking research on oxygen sensing and signalling pathways mediating cellular responses to low oxygen levels or 'hypoxia'.

What's behind the sudden rise in measles deaths in Europe?

What's behind the sudden rise in measles deaths in Europe?

Posted 14/07/2017

Deaths from measles have risen to new heights in Europe in the past year. The rapid spread of the measles virus has led to more than 3,300 cases and 35 deaths in Romania, Italy, Germany and Portugal. Researchers from the Jenner Institute discuss vaccination rates in an article recently published in The Conversation.

News Archive

Podcast: Meet our Researchers

Peter Horby

Emerging infectious diseases

Research on emerging infectious diseases can only be conducted during outbreaks. Although virology has improved, a well calibrated and effective public health response is often lacking. Epidemiological and clinical research as well as mathematical modelling will give us answers during the epidemics and help us.  Professor Peter Horby explains how his research focusses on epidemic diseases such as Ebola and bird flu.

View podcast

Medical Grand Rounds

Thu 15 Jun 1-2pm

JR Hospital
Lecture Theatre 1

Neurology: "Mitochondrial Parkinsonism: A case study in the era of Personalised Neurology". Dr George Tofaris

Palliative Care

Chair: Prof Chris O'Callaghan

View upcoming medical grand rounds

 Research Highlight

Eosinophils in COPD: just another biomarker?

Eosinophils in COPD: just another biomarker?

Posted 13/07/2017

Chronic obstructive pulmonary disease (COPD) is a common chronic lung disease associated with significant illness. Eosinophilic inflammation (immune cells usually associated with allergy) can help to inform us about which treatments will work the best in our patients with COPD according to research by Prof Mona Bafadhel, recently published in the Lancet.

View Research Highlights